Amicus Therapeutics: 3Q Earnings Snapshot

November 11, 2019

CRANBURY, N.J. (AP) _ Amicus Therapeutics Inc. (FOLD) on Monday reported a loss of $61.8 million in its third quarter.

On a per-share basis, the Cranbury, New Jersey-based company said it had a loss of 24 cents.

The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.

The pharmaceutical company posted revenue of $48.8 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $48.1 million.

Amicus Therapeutics expects full-year revenue in the range of $170 million to $180 million.

Amicus Therapeutics shares have decreased almost 7% since the beginning of the year. The stock has dropped 16% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD